MerckInc (MRK) has a profit margin of 3.64%, below the Healthcare sector average of 17.63%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2026
Trailing 12 months ending Sep 2026
The latest profit margin for MRK is 3.64% as of September 2026. That compares with 29.63% in the prior-year period — down 87.7% year over year. That is below the Healthcare sector average of 17.63%. Investors often review this figure alongside MerckInc's historical trend and sector peers before judging valuation or financial health.
Over the past year, MRK's profit margin moved from 29.63% to 3.64% — a 87.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in MerckInc's valuation or profitability profile.
Against Healthcare companies, MRK currently prints 3.64% for profit margin, while the sector average sits near 17.63%. That is roughly 79.3% below the sector mean. Large gaps often invite a closer look at MerckInc's growth, margins, and balance sheet.
Profit Margin shows how effectively MerckInc converts resources into returns. At 3.64%, MRK may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 29.63% in the prior-year period — down 87.7% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting MRK's profit margin (3.64%), review year-over-year change from 29.63%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.